AGM/EGMJul 31, 2026, 04:19 PM
Aptevo Schedules 2026 Annual Meeting; Key Proposals Include Director Elections, Stock Plan
AI Summary
Aptevo Therapeutics Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on August 21, 2026. Key proposals for stockholder vote include the election of two directors, ratification of the independent auditor, an advisory vote on executive compensation, and approval of the Fourth Amended and Restated 2018 Stock Incentive Plan. The company also noted recent changes in its board leadership structure, with Marvin L. White becoming Executive Chair and Jeffrey G. Lamothe assuming the role of President and CEO.
Key Highlights
- Annual Meeting of Stockholders scheduled for August 21, 2026, held virtually.
- Stockholders to vote on election of two directors to serve until the 2029 Annual Meeting.
- Proposal to ratify Baker Tilly US, LLP as independent registered public accounting firm for 2026.
- Advisory vote on 2025 executive compensation (Say-on-Pay Proposal).
- Proposal to approve the Fourth Amended and Restated 2018 Stock Incentive Plan.
- Record date for voting is July 23, 2026, with 1,517,945 shares outstanding.
- Marvin L. White transitioned to Executive Chair, and Jeffrey G. Lamothe became President and CEO in April 2026.
- John E. Niederhuber, M.D. appointed Lead Independent Director effective April 1, 2026.
Price Impact
More from APVO